how to tell if bpc 157 is bad BPC-157: Experimental Peptide Creates Risk for Athletes BPC-157: What It Is, What
Description
Odenwald and Turner 2013)
It is also important not to keep repeating injections to often as to do so can lead to tissue damage, particularly in the case of subacromial injections
Research on short-term fluid restriction suggests plasma volume doesnt change dramatically under ordinary, everyday hydration swings
Regulatory Status in Canada BPC-157 is not approved by Health Canada as a therapeutic product
